387 related articles for article (PubMed ID: 29077272)
1. Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.
Zhang Y; Wu B; Zhang H; Ge X; Ying S; Hu M; Li W; Huang Y; Wang L; Chen C; Shan X; Liang G
J Cell Mol Med; 2018 Feb; 22(2):936-947. PubMed ID: 29077272
[TBL] [Abstract][Full Text] [Related]
2. Blockade of myeloid differentiation protein 2 prevents obesity-induced inflammation and nephropathy.
Fang Q; Wang L; Yang D; Chen X; Shan X; Zhang Y; Lum H; Wang J; Zhong P; Liang G; Wang Y
J Cell Mol Med; 2017 Dec; 21(12):3776-3786. PubMed ID: 28767204
[TBL] [Abstract][Full Text] [Related]
3. Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2.
Zhu W; Sahar NE; Javaid HMA; Pak ES; Liang G; Wang Y; Ha H; Huh JY
Cells; 2021 Nov; 10(12):. PubMed ID: 34943814
[TBL] [Abstract][Full Text] [Related]
4. Myeloid Differentiation Protein 2 Mediates Angiotensin II-Induced Liver Inflammation and Fibrosis in Mice.
Zhang Y; Liu H; Jia W; Qi J; Zhang W; Zhang W; Liang G; Zhang Y; Chen AH
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861702
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis.
Fang Q; Wang J; Zhang Y; Wang L; Li W; Han J; Huang W; Liang G; Wang Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):252-262. PubMed ID: 28965884
[TBL] [Abstract][Full Text] [Related]
6. MD2 blockade prevents oxLDL-induced renal epithelial cell injury and protects against high-fat-diet-induced kidney dysfunction.
Xu S; Luo W; Xu X; Qian Y; Xu Z; Yu W; Shan X; Guan X; Lum H; Zhou H; Wang Y
J Nutr Biochem; 2019 Aug; 70():47-55. PubMed ID: 31151053
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
8. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
9. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.
Nozaki Y; Fujita K; Wada K; Yoneda M; Kessoku T; Shinohara Y; Imajo K; Ogawa Y; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
BMC Gastroenterol; 2015 Apr; 15():42. PubMed ID: 25881230
[TBL] [Abstract][Full Text] [Related]
12. Human germline hedgehog pathway mutations predispose to fatty liver.
Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E).
Bartolini D; Torquato P; Barola C; Russo A; Rychlicki C; Giusepponi D; Bellezza G; Sidoni A; Galarini R; Svegliati-Baroni G; Galli F
J Nutr Biochem; 2017 Sep; 47():120-131. PubMed ID: 28628909
[TBL] [Abstract][Full Text] [Related]
14. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2).
Xu Z; Li W; Han J; Zou C; Huang W; Yu W; Shan X; Lum H; Li X; Liang G
Sci Rep; 2017 Mar; 7():44911. PubMed ID: 28322341
[TBL] [Abstract][Full Text] [Related]
16. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
18. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes.
He Y; Hwang S; Cai Y; Kim SJ; Xu M; Yang D; Guillot A; Feng D; Seo W; Hou X; Gao B
Hepatology; 2019 Oct; 70(4):1150-1167. PubMed ID: 30964207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]